Introduction
Disease of the motor unit is common in children. These neuromuscular diseases may be genetically determined, congenital or acquired, acute or chronic, and progressive or static. (1) Neuromuscular disorders have limited clinical expression with considerable overlap of symptoms and signs. (2) Because of availability of new specific therapies for many diseases and for genetic
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Abstract Objective
Muscle biopsy is a very important diagnostic test in the investigation of a child with suspected neuromuscular disorder. The goal of this study was to review and evaluate pediatric muscle biopsies during a 2-year period with focus on histopathology diagnosis and correlations with other paraclinic studies.
Materials & Methods
We investigated 100 muscle biopsies belonging to patients with clinical impression of neuromuscular disorder. (2) Muscle biopsy has become the most essential diagnostic procedure in evaluating a child with neuromuscular disease.
To date, there is no comprehensive study about prevalence of muscular disorders among Iranian children.
The present study was performed to evaluate actual status of neuromuscular disorders in our patients who were candidate for muscle biopsy.
We 
Results
In this study100 patients (61% males and 39% females) were included. The patients at the time of muscle biopsy aged between 4 months to 15 years (Figure1).
The results indicated that only 20 cases had family history of muscle diseases (20% positive family history), fifty-eight patients were result of a consanguinity marriage.
The diagnostic results were as follow: muscular dystrophy was reported in 48 cases, out of which 10 were Duchenne muscular dystrophy, 13 were reported as Sarcoglycanopathy, among them 2 cases were suggested as alpha, 5 as gamma and 6 cases were suggested as beta sarcoglycanopathy. One of the dystrophic patients suffered from Dysferlinopathy and in 11 cases Merosin negative congenital muscular dystrophy was confirmed. IHC study was normal in 8 cases of muscular dystrophy and in 5 cases the data on IHC study is not available. Neurogenic atrophy was diagnosed in 18 cases, among them 14 cases were clinically or genetically confirmed as spinal muscular atrophy. Metabolic myopathies were diagnosed in 4 cases composed of 2 cases of juvenile Pompe and 2 cases of lipid storage myopathy. Congenital myopathy was reported in 6 cases out of which 4 were congenital myopathy with core lesions and 2 were Nemaline myopathy. One case of dermatomyositis was diagnosed. Selective type 2 fibers atrophy was seen in 5 cases and in 6 cases no specific histochemical pathologic finding was seen (Table 1) . Creatine Kinase was within abnormal limit in 66 cases and EMG was abnormal (myopathic or neurogenic patterns) in 79 cases.
There is a correlation in 50 cases (50%) of patients between abnormal CK level, EMG and muscle biopsy result as any myopathic finding (Figure 2 ). In spite of positive correlation between EMG and CK level in cases of myopathic results, biopsy results from 10 cases didn't demonstrate myopathy (Figure 2) . Degree of correlation between biopsy and EMG in patients less than 2 years of age was 18/3%, while in children more than 2 years of age was (82%), the difference between the 2 groups is statistically significant (Pvalue=0.012) ( Table 2) .
congenital muscular dystrophy in Iranian population but maybe it is due to our method of patient selection. Our study presents the largest documented case series of Merosin deficient congenital muscular dystrophy reported from Iran. We collected 6 cases with no specific histopathologic finding. The paucity of no specific findings in our muscle biopsy specimens may be due to orthodox selection of candidates for muscle biopsy. Degree of correlation between biopsy and EMG in patients < 2 years of age was 18/3%, while in children ≥ 2 years of age was 82%, the difference between the two groups is statistically significant (p value=0.012). These data show that EMG results are not reliable for children less than 2 years of age. This is in concordance with another study which shows EMG detection rate of myopathic motor unit potentials at a young age as low, improving in children over 2 years of age (6). This study confirms the high diagnostic yields of muscle biopsy especially only if standard and new techniques such as enzymes study and immunohistochemistry are implemented.
Discussion
In this study we do not present the frequency of neuromuscular disorders in Iranian children as we did not study 100 patients entering the neuromuscular clinic and we just studied 100 biopsy samples from patients who were candidates for muscle biopsy and this data is not representative of prevalence or frequency of muscle diseases in Iranian children.
Based on the present data muscular dystrophies were the most common type of neuromuscular disorders (48%) in our study like other studies (3, 4) , but in one study that was taken in India; SMA was the most common disorders (5) . The main reason is patient selection method; as many Iranian neurologists order "molecular genetic test" as the first-line work up in cases suspected of having SMA. We found 11cases (11%) of Merosin negative congenital muscular dystrophy in our study, while the incidence of this disorder was approximately 10 times more than the study reported from India (5). We believe that this is not because of the higher prevalence of Merosin negative 
